glp 1 a How long should you take GLP-1 drugs? Study links longer use to lower heart risk One in 10 people may

However, in the conventional arm ALT significantly increased and AST remained unchanged

GLP1R activation might reduce cardiovascular morbidity indirectly through reductions in glycaemia, blood pressure, inflammation, postprandial lipaemia and body weight

The cardiovascular outcome data are strong 1

In clinical trials, patients lost an average of 15% of their body weight after 12 months of taking semaglutide

Approached this way, GLP-1 therapy becomes less about a single number on the scale and more about a genuine, sustainable upgrade to your overall health

Journal of Nutritional Science and Vitaminology, 60 (1), 2227